Search Tag: diagnostic imaging

Executive Health Management

Affidea is Opening Two New Outpatient State-of-the-Art Clinics in Lithuania

2021 08 Oct

Affidea  is delighted to announce the launch of two brand new outpatient clinics in Lithuania, in Panevėžys and Šiauliai, both of them designed with a patient centric approach, offering an outstanding and comfortable experience to all our customers. The two new centers will provide patients with high quality medical services in contract... Read more

Executive Health Management

Know more, treat better

2019 22 May

Affidea applies ground-breaking AI technology on Brain MRI examinations for people with Multiple Sclerosis   Affidea has entered into a partnership with icometrix, a data science company that develops Artificial Intelligence (AI) solutions for healthcare, to standardise and improve the care of patients with neurological disorders. The official... Read more

Executive Health Management

Affidea grows in Portugal and expands into teleradiology

2018 23 May

Affidea Group is a leading healthcare services provider with over 7500 professionals performing almost 13 million examinations each year. Affidea is recognised for its superior medical technology platform, scale efficiencies, internationally awarded medical excellence and its continued expansion into new ways to create value as an integrator provider... Read more

Executive Health Management

Alliar: Innovations for a country of continental dimensions

2018 23 May

Alliar’s innovative business model and IT systems mean that patients in remote locations have access to standardised, high-quality exams in any of its patient centres across Brazil.   Intro: Parauapebas   Parauapebas is a small town located in north Brazil, next to the Amazon rainforest. It sits 2,000 km away from São Paulo, the country’s... Read more

Executive Health Management

Cancer Drug Costs Need to Drop

2015 08 Aug

In a manifesto, a group of eminent oncologists note how the steep prices of cancer drugs are affecting the care of patients with cancer. They cite data showing that in 2014 all new FDA-approved cancer drugs were priced above $120,000 per year of use. They are calling for a reduction in drug prices.   While the skyrocketing drug prices may be driving... Read more